Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2016-07-18 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75019), Paris
PHARMACIE SECRETAN : revenue, balance sheet and financial ratios
PHARMACIE SECRETAN is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75019),
this company of category PME
shows in 2022 a revenue of 8.0 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE SECRETAN (SIREN 821289238)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
8 044 220 €
10 188 302 €
N/C
N/C
8 888 617 €
11 767 429 €
Net income
852 919 €
900 812 €
1 034 565 €
1 291 081 €
382 235 €
451 367 €
380 959 €
287 653 €
EBITDA
N/C
N/C
1 471 637 €
1 941 593 €
N/C
N/C
716 190 €
696 054 €
Net margin
N/C
N/C
12.9%
12.7%
N/C
N/C
4.3%
2.4%
Revenue and income statement
In 2024, PHARMACIE SECRETAN generates positive net income of 853 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 288 k€ -> 853 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
852 919 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 152%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
152.361%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
35.442%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
2264.86
930.541
520.655
443.879
222.22
417.258
256.405
152.361
Financial autonomy
3.429
7.802
12.949
15.099
25.301
16.913
24.829
35.442
Repayment capacity
17.518
12.108
None
None
4.364
6.787
None
None
Cash flow / Revenue
3.27%
5.867%
None%
None%
14.01%
14.045%
None%
None%
Sector positioning
Debt ratio
152.362024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE SECRETAN (152.36) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
35.44%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE SECRETAN (35.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
6.79 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE SECRETAN (6.79) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 340.03. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
340.033
Liquidity indicators evolution PHARMACIE SECRETAN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
117.483
120.367
129.201
185.184
204.254
299.331
357.129
340.033
Interest coverage
35.079
14.825
None
None
4.959
5.286
None
None
Sector positioning
Liquidity ratio
340.032024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent
In 2024, the liquidity ratio of PHARMACIE SECRETAN (340.03) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
5.29x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of PHARMACIE SECRETAN (5.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE SECRETAN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
619 908 €
746 822 €
0 €
0 €
1 064 270 €
1 626 702 €
0 €
0 €
Inventory turnover (days)
41
62
0
0
51
73
0
0
Customer payment term (days)
2
2
0
0
5
6
0
0
Supplier payment term (days)
28
41
0
0
59
67
0
0
Positioning of PHARMACIE SECRETAN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE SECRETAN is estimated at
11 907 379 €
(range 8 292 111€ - 17 814 121€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
8292k€11907k€17814k€
11 907 379 €Range: 8 292 111€ - 17 814 121€
NAF 5 année 2024
Valuation method used
Net Income Multiple
852 919 €
×
14.0x
=11 907 380 €
Range: 8 292 111€ - 17 814 121€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE SECRETAN with other companies in the same sector:
Frequently asked questions about PHARMACIE SECRETAN
What is the revenue of PHARMACIE SECRETAN ?
The revenue of PHARMACIE SECRETAN in 2022 is 8.0 M€.
Is PHARMACIE SECRETAN profitable?
Yes, PHARMACIE SECRETAN generated a net profit of 853 k€ in 2024.
Where is the headquarters of PHARMACIE SECRETAN ?
The headquarters of PHARMACIE SECRETAN is located in PARIS (75019), in the department Paris.
Where to find the tax return of PHARMACIE SECRETAN ?
The tax return of PHARMACIE SECRETAN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE SECRETAN operate?
PHARMACIE SECRETAN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart